Articles Anti-seizure medication improves cognitive function in some Alzheimer’s patients 09/27/2021
An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer’s patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.
Articles ESMO: New drug shows promise in treating early-stage breast cancer Study is first to report compari 09/22/2021
Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy, called an oral selective estrogen receptor degrader (SERD), led to clinically meaningful reductions in tumor activity prior to surgery.
Articles How a new imaging tool helps to better stage men with prostate cancer 09/20/2021
Prostate-specific membrane antigen, or PSMA, -targeted PET imaging for prostate cancer has been a breakthrough diagnosis tool in locating prostate cancer tumors for more precise treatment. The new imaging technique can locate cancer lesions not only in the prostate, but can also track cancer that has spread to other parts of the body that is often missed by current standard-of-care imaging techniques.
Articles 2021 Hospital CEO or President of the Year Honoree: Johnese Spisso 08/25/2021
With 30 years of experience, Johnese Spisso is a nationally recognized academic health care leader, overseeing operations of UCLA’s hospitals, clinics and the health system’s regional outreach strategy.
Articles Sequential-combinatorial regimens can make treatment more effective for people with aggressive cancers 08/23/2021
A new preclinical study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that treating people who have aggressive cancers, including melanoma, pancreatic and colorectal cancers, with immune checkpoint inhibitors, quickly followed with mutation-targeted therapy, can help overcome treatment resistance and help people live longer.
Articles U.S. kidney transplant survival rates continue to improve 08/18/2021
Long-term survival rates of kidney transplant patients in the U.S. have increased over the last three decades, but there are opportunities to further improve these outcomes, according to a review article published in The New England Journal of Medicine.
